Treating Covid-19: Clinical trials using arthritis drug get nod
“The CDSCO (Central Drugs Standard Control Organisation) has approved a vital randomised controlled trial on Covid-19 treatment with a biological called tocilizumab, in the first proposed multi-centre trial with the drug in India,” said Dr AS Soin, national lead investigator for the trial.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Actemra | Arthritis | Biotechnology | Clinical Trials | COVID-19 | India Health | Pharmaceuticals | Rheumatology